Immunoinformatics and Vaccine Design
A special issue of Vaccines (ISSN 2076-393X).
Deadline for manuscript submissions: closed (15 April 2024) | Viewed by 424
Special Issue Editor
Special Issue Information
Dear Colleagues,
The concept of vaccination has progressed considerably since its introduction more than two hundred years ago. While traditional approaches have saved millions of lives, to combat rapidly evolving viruses such as influenza and coronaviruses, as well as the sustained use of candidate vaccines, a new method of designing vaccines is required. Immunoinformatics combines computational approaches to indicate variation in pathogens and provide knowledge on the immune system, and could facilitate the design of novel vaccine candidates with improved broad-spectrum effectiveness against emerging pathogens and their variants. The field of immunoinformatics is still in its infancy, but it is expected that experimental data from vaccine candidates designed using immunoinformatics approaches will help standardize immunoinformatics-based vaccine design strategies.
COVID-19 has forced researchers to explore the use of immunoinformatics for designing vaccine candidates, not only for COVID-19, but also for several other pathogens.
This Special Issue aims to present an invaluable collection of papers on recent trends and developments in the rapidly evolving field of immunoinformatics. We welcome papers on any subject area related to “immunoinformatics”, and encourage researchers to submit work containing experimental data on candidate vaccines designed using the immunoinformatics approach.
Prof. Dr. Kiran Kondabagil
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- immunoinformatics
- subunit vaccines
- precision epitope prediction
- linear and conformational epitopes
- neutralizing antibodies
- cell-mediated immune response
- humoral immune response
- toll-like receptors
- linkers and peptide adjuvants
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
